Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 4, 2009, Pages 354-360

  Dalby, Tine ^a   Seier Petersen, Maria ^a   Kristiansen, Max Per ^a   Harboe, Zitta Barrella ^a   Krogfelt, Karen Angeliki ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Heat inactivation; Human; Pertussis enzyme linked immunosorbent assay; Pertussis toxin; Serology; Serum

Indexed keywords

BUFFER; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HEAT TREATMENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MILK; PERTUSSIS; PRIORITY JOURNAL; PROBLEM SOLVING; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE; THERMAL EXPOSURE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTITOXINS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; MIDDLE AGED; PERTUSSIS TOXIN; PERTUSSIS VACCINE; SENSITIVITY AND SPECIFICITY; WHOOPING COUGH; YOUNG ADULT;

EID: 62549085100     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.12.004     Document Type: Article

References (38)

1. Andre P., Caro V., Njamkepo E., Wendelboe A.M., Van Rie A., and Guiso N. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J. Clin. Microbiol. 46 (2008) 1672-1677
2. Arico B., and Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J. Bacteriol. 169 (1987) 2847-2853
3. Baughman A.L., Bisgard K.M., Edwards K.M., Guris D., Decker M.D., Holland K., Meade B.D., and Lynn F. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11 (2004) 1045-1053
4. Cagney M., Macintyre C.R., McIntyre P., Puech M., and Giammanco A. The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiol. Infect. 134 (2006) 1208-1216
5. Cevik M., Beyazova U., Aral A.L., Duyan C.A., Ozkan S., Sahin F., and Aybay C. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey. Clin. Microbiol. Infect. 14 (2008) 388-390
6. Costa O., Marion C., Monier J.C., and Roux B. Non-specific binding of heat-aggregated IgG to histone detected by ELISA. J. Immunol. Methods 74 (1984) 283-291
7. Crowcroft N.S., and Pebody R.G. Recent developments in pertussis. Lancet 367 (2006) 1926-1936
8. D'Cruz D.P., Keser G., Direskeneli H., Khamashta M.A., and Hughes G.R. Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity. Clin. Exp. Immunol. 115 (1999) 567-570
9. de Melker H.E., Versteegh F.G., Conyn-van Spaendonck M.A., Elvers L.H., Berbers G.A., van Der Z.A., and Schellekens J.F. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38 (2000) 800-806
10. Francis J.M., Payne R.A., and Joynson D.H. Rapid indirect enzyme linked immunosorbent assay (ELISA) for detecting antitoxoplasma IgG: comparison with dye test. J. Clin. Pathol. 41 (1988) 802-805
11. Gabutti G., Bergamini M., Bonanni P., Guido M., Fenoglio D., Giammanco A., Sindoni L., Zotti C., Boddi V., Bamfi F., Severini R., Bechini A., Boccalini S., and Crovari P. Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy. Epidemiol. Infect. 136 (2008) 1576-1584
12. Giammanco A., Chiarini A., Maple P.A., Andrews N., Pebody R., Gay N., Olander R.M., Fivet-Groyne F., Baron S., Tischer A., Swidsinski S., Schellekens J., and Reizenstein E. European sero-epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22 (2003) 112-120
13. Gombosova A., and Valent M. Effect of heat inactivation of sera on anti-Trichomonas vaginalis IgG ELISA. J. Clin. Pathol. 42 (1989) 1116-1117
14. Guiso N., Njamkepo E., Vie L.S., Zepp F., Meyer C.U., Abitbol V., Clyti N., and Chevallier S. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 25 (2006) 1390-1397
15. Hallander H.O., Gustafsson L., Ljungman M., and Storsaeter J. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 23 (2005) 5359-5364
16. Hasselaar P., Triplett D.A., LaRue A., Derksen R.H., Blokzijl L., de Groot P.G., Wagenknecht D.R., and McIntyre J.A. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. J. Rheumatol. 17 (1990) 186-191
17. Ibsen P.H. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 14 (1996) 359-368
18. Jackson L.A., Cherry J.D., Wang S.P., and Grayston J.T. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin. Infect. Dis. 31 (2000) 3-6
19. Jungkind D.L., DiRenzo S.A., and Young S.J. Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test. J. Clin. Microbiol. 23 (1986) 381-382
20. Knuf M., Zepp F., Meyer C., Grzegowski E., Wolter J., Riffelmann M., and Wirsing von Konig C.H. Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population. Vaccine 24 (2006) 2043-2048
21. Layton G.T., Johnston S.C., and Bertwistle N.G. Serum factors affecting the specificity of anticardiolipin antibodies. Immunol. Cell Biol. 69 Pt 1 (1991) 17-25
22. Le T., Cherry J.D., Chang S.J., Knoll M.D., Lee M.L., Barenkamp S., Bernstein D., Edelman R., Edwards K.M., Greenberg D., Keitel W., Treanor J., and Ward J.I. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J. Infect. Dis. 190 (2004) 535-544
23. Littmann M., Hulsse C., Riffelmann M., and Wirsing von Konig C.H. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers. Vaccine 26 (2008) 2344-2349
24. Lopez A.L., Pineda E., Garakian A., and Cherry J.D. Effect of heat inactivation of serum on Bordetella pertussis antibody determination by enzyme-linked immunosorbent assay. Diagn. Microbiol. Infect. Dis. 30 (1998) 21-24
25. Lynn F., Reed G.F., and Meade B.D. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab. Immunol. 3 (1996) 689-700
26. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18 (2005) 326-382
27. Nardone A., Pebody R.G., Maple P.A., Andrews N., Gay N.J., and Miller E. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine 22 (2004) 1314-1319
28. Noguchi H. The thermostabile anticomplementary constituents of the blood. J. Exp. Med. 8 (1906) 726-753
29. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., Olander R.M., Andrews N.J., Edmunds W.J., Lecoeur H., Levy-Bruhl D., Maple P.A., de Melker H., Nardone A., Rota M.C., Salmaso S., Conyn-van Spaendonck M.A., Swidsinski S., and Miller E. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 133 (2005) 159-171
30. Soltis R.D., Hasz D., Morris M.J., and Wilson I.D. The effect of heat inactivation of serum on aggregation of immunoglobulins. Immunology 36 (1979) 37-45
31. Spire B., Dormont D., Barre-Sinoussi F., Montagnier L., and Chermann J.C. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet 1 (1985) 188-189
32. Tada Y., Ishikawa T., Chazono M., Yoshida I., and Nii R. Effect of serum treatment on pertussis antibody determination by ELISA. Dev. Biol. Stand. 73 (1991) 175-184
33. Tozzi A.E., Pandolfi E., Celentano L.P., Massari M., Salmaso S., and Atti M.L. Comparison of pertussis surveillance systems in Europe. Vaccine 25 (2006) 291-297
34. Vermeer A.W., and Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys. J. 78 (2000) 394-404
35. Watanabe M., Connelly B., and Weiss A.A. Characterization of serological responses to pertussis. Clin. Vaccine Immunol. 13 (2006) 341-348
36. World Health Organization Department of Immunization Vaccines and Biologicals (2004) Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis/Bordetella parapertussis. Immunization, vaccines and biologicals. World Health Organization 04.14.
37. World Health Organization Department of Vaccines and Biologicals (2003) WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Vaccines and biologicals, World Health Organization 03.01.
38. Yoshida H., Imafuku Y., and Nagai T. Matrix effects in clinical immunoassays and the effect of preheating and cooling analytical samples. Clin. Chem. Lab. Med. 42 (2004) 51-56